The House Energy and Commerce Committee today held Congress’ first oversight hearing since the enactment of the Biologics Price Competition and Innovation Act in 2010.
The National Community Pharmacists Association and the Iowa Pharmacy Association have filed an amicus curiae brief in the United States Court of Appeals for the Eighth Circuit in support of the state of Iowa and against a challenge by the Pharmaceutical Care Management Association to the state’s MAC transparency law.
ASHP and the American Pharmacists Association today approved the new standard for PGY1 Community-based Pharmacy Residency Programs.
Increased transparency into the business practices and potential conflicts of interests of pharmacy benefit manager corporations could provide tangible benefits to payers, patients and pharmacists, the National Community Pharmacists Association said in comments submitted to the House Committee on Oversight and Government Reform, which held a hearing today on the prescription drug market.
Today the Campaign for Sustainable Rx Pricing announced that ASHP has officially joined the coalition.
Pharmacy Market News
Allergan has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.
Johnson & Johnson has announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action announced at the World Economic Forum in Davos, Switzerland.
Strategic Alliance Partner News
AmerisourceBergen Corporation and Publix have announced a long-term agreement encompassing the distribution of branded, generic and over-the-counter health and pharmaceutical products.
For hospitals considering enrollment in the Federal 340B Drug Pricing Program, the Health Resources and Services Administration's recent Omnibus Guidance could have significant impact on plans and operations.